Curcumin for Tumours
Scientists are excited about curcumin because it has been shown consistently to inhibit NF-kB. A lot of the research into curcumin has focused on cancers. According to cancer researcher Bharat Aggarwal a professor of cancer medicine at the MD Anderson Cancer Centre University of Texas, the incidence of the top four cancers in the U.S. - colon, breast, prostate and lung is as much as ten times lower in India where significant amounts of turmeric are consumed daily. Prof Aggarwal's hypothesis is that most cancers exhibit activated NF-kB which in turn promotes the proliferation and metastasis of tumours. Blocking of NF-kB suppresses the formation of tumours.
Turmeric as appears to reduce the risk of cancer, a study by Inano et al., (2000) looked at the risk of tumours in rats following whole body exposure to X-irradiation. They found that 70.3% of the mice developed tumours. However, in the group of rats receiving 1% curcumin (turmeric extract) in their diet, the risk of tumour development was only 18.5%. Further studies have also demonstrated reduced risk of cancer following turmeric supplementation (Huang et al., 1997; Limtrakul et al., 1997). It is believed that the curcumin, within turmeric, is able to suppress tumour formation as well as interfering with the processes involved in tumour progression (Gescher et al., 2001) and is also able to protect against DNA damage (Ahsan et al., 1999). Curcumin is considered to be a safe and non-toxic cancer preventative agent (Goel et al., 2001). The curcumin within turmeric may therefore prove to be an effective means of reducing the risk of certain cancers. It blocks tumour growth instigated by chemical carcinogens such as mutagens in tobacco smoke. Curcumin also suppresses cancer by maintaining DNA methylation, which controls access to genes that may be harmful. This stops several genes that support tumour survival and inhibits DNA damage that can cause chronic diseases.
A current hot topic in oncology is the recruitment of bone-marrow derived stem cells to manage inflammation in and around tumours. These highly mobile and pluripotent cells (meaning that they can have more than one potential outcome) may confer the most malignant properties to the tumour, namely invasion and metastasis (increased spread). They are also capable of prolonged dormancy and are therefore resistant to chemotherapy and radiation. Controlling inflammation must be a core part of any cancer protocol.
Curcumin is useful in radiation therapy, improving safety and efficacy. I do not recommend giving curcumin with chemotherapy, although there is some evidence that it may be useful. However, it is safe and most desirable to use it after chemotherapy, for detoxification and tumour suppression.
Indications of Curcumin Capsules
- Arthritis of All types – Osteoarthritis, Rheumatoid, Ankylosing, Psoriatic
- Recurrent Sinusitis, Allergies, Asthma, Chronic Rhinitis, Eosinophilea
- Strains, sprains and sports injuries
- Cancers of All types
- Alzhiemer’s disease
- Prostate enlargement
- Inflammatory conditions of any organ
OUR CURCUMIN CAPSULES
Planet Ayurveda Curcumin gives the best results than the other similar supplements from other companies. The reason is that we use standardized 500 mg extract of curcumin containing 95 % curcuminoids in pure vegetarian capsule shells.
Just 97.95 $ for 5 bottles
Each Bottle contains
60 Vegi Capsules
Serving Size- 1-2 Vegi Cap
Servings Per Container - 30 to 60
Each 500 mg Capsule Contains – Best Quality Herbal standardized Extract of Curcumin 10:1 (containing 95% curcuminoids)
WE SELL THE BEST QUALITY CURCUMIN CAPSULES IN THE WORLD - TRY THEM !
Dosage of Curcumin Capsules
2 capsules twice daily, with plain water after meals for inflammation. 3-4 capsules can be consumed in case of various cancer. 1 capsule twice daily is good as natural anti-oxidant.
Our curcumin capsules contain 100 % herbal extract of standardized curcumin extract upto 95 % curcuminoids and we do not fill any powders, fillers or herbs. We use pure vegetarian shells and not hard gelatin shells.